Cargando…
Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice
Cholera toxin (CT) induces severe diarrhea in humans but acts as an adjuvant to enhance immune responses to vaccines when administered orally. Nasally administered CT also acts as an adjuvant, but CT and CT derivatives, including the B subunit of CT (CTB), are taken up from the olfactory epithelium...
Autores principales: | Fukuyama, Yoshiko, Okada, Kazunari, Yamaguchi, Masahiro, Kiyono, Hiroshi, Mori, Kensaku, Yuki, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589288/ https://www.ncbi.nlm.nih.gov/pubmed/26422280 http://dx.doi.org/10.1371/journal.pone.0139368 |
Ejemplares similares
-
Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
por: Kim, Donghyun, et al.
Publicado: (2016) -
The Respiratory Commensal Bacterium Corynebacterium pseudodiphtheriticum as a Mucosal Adjuvant for Nasal Vaccines
por: Ortiz Moyano, Ramiro, et al.
Publicado: (2023) -
Potential Roles of CCR5(+) CCR6(+) Dendritic Cells Induced by Nasal Ovalbumin plus Flt3 Ligand Expressing Adenovirus for Mucosal IgA Responses
por: Fukuyama, Yoshiko, et al.
Publicado: (2013) -
Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit
por: Ogawa, Takumi, et al.
Publicado: (2017) -
Comparative whole-genome analyses of selection marker–free rice-based cholera toxin B-subunit vaccine lines and wild-type lines
por: Kashima, Koji, et al.
Publicado: (2015)